Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

KLLN anticorps (C-Term)

KLLN Reactivité: Humain WB Hôte: Lapin Polyclonal RB29503 unconjugated
N° du produit ABIN655558
  • Antigène Voir toutes KLLN Anticorps
    KLLN (Killin, p53-Regulated DNA Replication Inhibitor (KLLN))
    Épitope
    • 7
    • 7
    • 7
    • 1
    • 1
    • 1
    AA 136-163, C-Term
    Reactivité
    Humain
    Hôte
    • 25
    Lapin
    Clonalité
    • 25
    Polyclonal
    Conjugué
    • 8
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp KLLN est non-conjugé
    Application
    • 17
    • 14
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogène
    This KILLIN antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 136-163 amino acids from the C-terminal region of human KILLIN.
    Clone
    RB29503
    Isotype
    Ig Fraction
  • Indications d'application
    WB: 1:500
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
    Date de péremption
    6 months
  • Wang, Roma, Nolley, Abdul-Karim, Peehl, Eng: "Nuclear KLLN expression associates with improved relapse-free survival for prostate carcinoma." dans: Endocrine-related cancer, Vol. 21, Issue 4, pp. 579-86, (2014) (PubMed).

    Wang, Yu, He, Romigh, Altemus, Eng: "Activation of AR sensitizes breast carcinomas to NVP-BEZ235's therapeutic effect mediated by PTEN and KLLN upregulation." dans: Molecular cancer therapeutics, Vol. 13, Issue 2, pp. 517-27, (2014) (PubMed).

    Wang, He, Yu, Eng: "Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomas." dans: Human molecular genetics, Vol. 22, Issue 11, pp. 2263-72, (2013) (PubMed).

  • Antigène
    KLLN (Killin, p53-Regulated DNA Replication Inhibitor (KLLN))
    Autre désignation
    KILLIN (KLLN Produits)
    Synonymes
    anticorps CWS4, anticorps KILLIN, anticorps killin, p53-regulated DNA replication inhibitor, anticorps KLLN
    Sujet
    DNA-binding protein involved in S phase checkpoint control-coupled apoptosis by mediating TP53/p53-induced apoptosis. Has the ability to inhibit DNA synthesis and S phase arrest coupled to apoptosis. Has affinity to both double-and single-stranded DNA.
    Poids moléculaire
    19958
    ID gène
    100144748
    NCBI Accession
    NP_001119521
    UniProt
    B2CW77
Vous êtes ici:
Support technique